Join free webinar on China Drug Master File (DMF) Filing for APIs, Excipients & Packaging Materials (click here to register) on Thursday 15th April, 2021, at 10:30 CEST time. The webinar will provide an overview of the requirements, regulatory pathways, how to register your DMF in China and a comparison between US FDA and EMA DMF systems and much more! Accestra and ELC group who are co-hosting, look forward to your participation.

1. China Regulatory Framework & Registration Pathways
2. Comparison between China, EU & US
3. Technical requirements: Pitfalls & Tips
4. Questions and Answers

• Date: Thursday 15^th April, 2021
• Time: 10:30 AM CEST
• Price: Free of charge

Click here to register. You will then receive an invitation to this webinar. Please note that the number of participants is limited.

• Raymond Ng: Business Development Director from Accestra Consulting
• Chetan Javia: Senior Expert of Strategic Alliance & Regulatory Affairs from ELC Group.

China is one of the fastest growing market for drug APIs, Excipients & Packaging Materials. Due to significant reform, increased demands for pharmaceutical drugs, and increasing government investment in healthcare and R&D, the market is being primed for a major boost in the coming years.

Accestra Consulting Provides China Regulatory Affairs Outsourcing for Drugs/Pharmaceutical, Food and Feed products for China NMPA (Formerly CFDA) regulatory approval including product registration for China, China Drug Master File (DMF) for APIs, Excipient and Packaging Materials and others. For more information you may email: info@accestra.com

ELC Group is a fully-fledged global regulatory partner, working with major pharmaceutical stakeholders for over a decade. ELC provides a range of solutions through 3 divisions: Pharmaceutical, Medical devices and Translations. For more information you may email: info@elc-group.com